Developing biomarkers for the early detection of age related diseases
.svg){kind=small}
Welcome to Age Labs
.svg){kind=icon}
Age Labs is a Norwegian life science company that discovers, develops and commercializes diagnostic tests for the early detection of age-related diseases. Our pipeline includes a test for early detection of rheumatoid arthritis, a biological age predictor and a test predicting the severity of COVID-19 infection. Our service includes developing biomarkers for use in clinical trials and studying epigenetic drug effects.
Our Service
Age Labs provides biomarker development and comprehensive reports on epigenetic drug effects for use in clinical trials.
Our main customers are companies from the pharmaceutical and nutraceutical industry.
R&D Pipeline
By using advanced machine learning on epigenetic datasets from biobanks, we develop biomarkers for the early detection of diseases.
Our first diagnostic candidate is a test for the early detection of rheumatoid arthritis.
We have several R&D projects in collaboration with pharma companies and public institutions in Norway.
For a quote
.svg){kind=icon}
© 2017-2023 Age Labs AS, reg.no 919.825.723.